Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00736073 · ClinicalTrials.gov registry record · NA
A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT00736073 is a NA study that has completed, run by Duke University. The registered enrollment target is 73 participants.
The verdict
NCT00736073, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if giving Aprepitant 4 hours before and for two days after ERCP decreases the risk of developing pancreatitis after ERCP.
Interventions
- DRUG Placebo
- DRUG aprepitant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00736073
The ClinicalTrials.gov registry entry for NCT00736073 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00736073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00736073 about?
NCT00736073 is a clinical study titled "A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis". The purpose of this study is to determine if giving Aprepitant 4 hours before and for two days after ERCP decreases the risk of developing pancreatitis after ERCP.
What is the current status of trial NCT00736073?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2007-08. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00736073?
The interventions under investigation include: Placebo (DRUG), aprepitant (DRUG).
Who is sponsoring clinical trial NCT00736073?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.